Clare Ozawa - May 12, 2021 Form 4 Insider Report for Oyster Point Pharma, Inc. (OYST)

Role
Director, 10%+ Owner
Signature
/s/ Robin L. Praeger, Attorney-in-Fact for Clare Ozawa
Stock symbol
OYST
Transactions as of
May 12, 2021
Transactions value $
$0
Form type
4
Date filed
5/14/2021, 04:44 PM
Next filing
Jun 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OYST Common Stock Other $0 -320K -19.05% $0.00 1.36M May 12, 2021 See Footnotes F1, F2
transaction OYST Common Stock Other $0 +82.5K $0.00 82.5K May 12, 2021 See Footnotes F3, F4
transaction OYST Common Stock Other $0 -82.5K -100% $0.00* 0 May 12, 2021 See Footnotes F4, F5
transaction OYST Common Stock Other $0 +193 +2.69% $0.00 7.36K May 12, 2021 Direct F6
transaction OYST Common Stock Other $0 -2.02K -19.31% $0.00 8.43K May 12, 2021 See Footnotes F7, F8
holding OYST Common Stock 2.24M May 12, 2021 See Footnotes F9
holding OYST Common Stock 1M May 12, 2021 See Footnotes F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. ("Versant IV") to its partners.
F2 Shares held by Versant IV. Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of Versant IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant IV, except to the extent of its pecuniary interest therein.
F3 Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV.
F4 Shares held by Versant Ventures IV.
F5 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV, to its members.
F6 Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures IV.
F7 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. ("Versant Side Fund IV") to its partners.
F8 Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of its pecuniary interest therein.
F9 Shares held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the sole general partner of Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") and Versant Ventures VI GP is the sole general partner of Versant VI. The Reporting Person, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP and the Reporting Person disclaims beneficial ownership of the shares held by Versant VI, except to the extent of their respective pecuniary interests therein.
F10 Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("Versant Vantage I GP") and Versant Vantage I GP is the sole general Partner of Versant Vantage. The Reporting Person, a member of the Issuer's board of directors, is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage. Each of Versant Vantage I GP-GP, Versant Vantage I GP, and the Reporting Person disclaims beneficial ownership of the shares held by Versant Vantage, except to the extent of their respective pecuniary interests therein.